🇫🇷·Mar 24Regulatory
The Impact of Next Generation Sequencing (NGS) on Quality Control of Pharmaceutical Products.
Publisher
A
A3P France
France
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- A3P France
- Region
- France
- Scope
- Regulatory
- Published
- March 24, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on a3p.org
Leave the platform to read the original full article on the publisher site.
Source: A3P France
Scope: Regulatory
Related coverage
More related coverage
PMDA Japan·1d ago
[IBENTO][IBENTO]Workshop on New Approach Methodologies (NAMs) Held following ICCR-20
LEEM France·1d ago
Jean-François Brochard élu Président du Leem et composition du nouveau Bureau
BioWorld NMPA RSS·1d ago
Innovent submits NDA for CLDN18.2 ADC for gastric cancer
BioWorld NMPA RSS·1d ago